ARTV Artiva Biotherapeutics, Inc. - Common Stock
$8,80
Prezzo · Mag 20, 2026
Fondamentali al Mag 8, 2026
Intervallo 52 sett.
$1–$15
56% of range
Rating Analisti
BUY
12 analysts
Prezzo Obiettivo
$31
+255% upside
P/E (TTM)
-1.3
ROE
—
Margine di Profitto Netto
—
ARTV Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$8.80
Capitalizzazione di Mercato
—
P/E (TTM)
-1.3
EPS (TTM)
$-3.43
Ricavi (TTM)
$0
Rendimento div.
—
ROE
—
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$1 – $15
ARTV Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$0
2023-12-31
→
2025-12-31
EPS
$-3.43
2023-12-31
→
2025-12-31
Flusso di cassa libero
—
2024-12-31
→
2024-12-31
Margini
—
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
ARTV
Mediana dei peer
P/E (TTM)
-1.3
2.4
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
ARTV
Mediana dei peer
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
ARTV
Mediana dei peer
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
ARTV
Mediana dei peer
Revenue YoY (Ricavi YoY)
-99.2%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
ARTV
Mediana dei peer
ARTV Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
12 analisti
- Acquisto forte 4 33,3%
- Compra 7 58,3%
- Mantieni 1 8,3%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
5 analisti · 2026-05-19
Mediana
$35.00
Media
$31.20
← Sotto tutti i target
$8.80
Basso
$18.00
Alto
$40.00
Target mediano
$35.00
+297,7%
Target medio
$31.20
+254,5%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.02%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $-0.95 | $-0.89 | -0.06% |
| 31 Dicembre 2025 | $-0.85 | $-0.84 | -0.01% |
| 30 Settembre 2025 | $-0.88 | $-0.89 | 0.01% |
| 30 Giugno 2025 | $-0.87 | $-0.82 | -0.05% |
| 31 Marzo 2025 | $-0.83 | $-0.72 | -0.11% |
| 31 Dicembre 2024 | $-0.66 | $-0.77 | 0.11% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| ARTV | — | -1.3 | -99.2% | — | — | — |
| TLSI | — | — | — | — | — | — |
| ARCT | $174M | -2.6 | -46.1% | -80.2% | -29.6% | — |
| NBP | — | — | — | — | — | — |
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| ELTX | — | -3.1 | — | — | — | — |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | — |
| DTIL | $100M | -1.2 | -50.1% | -133.4% | -72.4% | — |
| CRBP | $143M | -1.4 | — | — | -60.8% | — |
| KPTI | $135M | -0.4 | 0.57% | -134.2% | 73.7% | — |
| TNYA | $154M | -1.2 | — | — | -81.2% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 14
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $251.0K | $33M | |
| R&D Expense | $70M | $50M | $50M | |
| SG&A Expense | $20M | $17M | $14M | |
| Operating Expenses | $90M | $68M | $64M | |
| Operating Income | $-90M | $-67M | $-31M | |
| Other Non-op | $-14.0K | $157.0K | $195.0K | |
| Pretax Income | · | $-65M | $-29M | |
| Income Tax | $0 | $0 | $72.0K | |
| Net Income | $-84M | $-65M | $-29M | |
| EPS (Basic) | $-3.43 | $-5.81 | $-35.78 | |
| EPS (Diluted) | $-3.43 | $-5.81 | $-35.78 | |
| Shares (Basic) | 24,444,057 | 11,258,851 | 802,747 | |
| Shares (Diluted) | 24,444,057 | 11,258,851 | 802,747 | |
| EBITDA | · | $-65M | · |
Stato Patrimoniale 22
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $40M | $54M | |
| Short-term Investments | $81M | $145M | $23M | |
| Receivables | · | $0 | $1M | |
| Prepaid Expense | $5M | $3M | $1M | |
| Current Assets | $113M | $189M | $80M | |
| PP&E (Net) | $7M | $6M | $8M | |
| PP&E (Gross) | $15M | $12M | $12M | |
| Accum. Depreciation | $8M | $6M | $4M | |
| Other Non-current Assets | $458.0K | $267.0K | $392.0K | |
| Total Assets | $131M | $210M | $105M | |
| Accounts Payable | $355.0K | $1M | $614.0K | |
| Accrued Liabilities | $10M | $7M | $8M | |
| Current Liabilities | $13M | $12M | $12M | |
| Capital Leases | $8M | $11M | $13M | |
| Other Non-current Liabilities | · | $73.0K | $73.0K | |
| Total Liabilities | $21M | $23M | $51M | |
| Common Stock | $3.0K | $3.0K | · | |
| Retained Earnings | $-331M | $-247M | $-181M | |
| AOCI | $103.0K | $-129.0K | $308.0K | |
| Stockholders' Equity | $110M | $187M | $-162M | |
| Liabilities + Equity | $131M | $210M | $105M | |
| Shares Outstanding | 24,595,550 | 24,291,607 | 809,758 |
Flusso di cassa 11
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $3M | $2M | $2M | |
| Stock-based Comp | $7M | $7M | $7M | |
| Other Non-cash | · | $930.0K | · | |
| Operating Cash Flow | $-77M | $-55M | $-47M | |
| CapEx | $3M | $642.0K | $3M | |
| Investing Cash Flow | $63M | $-120M | $-26M | |
| Stock Issued | $0 | $167M | · | |
| Net Stock Activity | · | $167M | · | |
| Financing Cash Flow | $9.0K | $162M | $24M | |
| Net Change in Cash | $-13M | $-13M | $-49M | |
| Free Cash Flow | · | $-56M | · |
Redditività 7
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -26805.6% | · | |
| Net Margin | · | -26045.0% | · | |
| Pretax Margin | · | -26045.0% | · | |
| EBITDA Margin | · | -25837.0% | · | |
| ROA | · | -41.5% | · | |
| ROE | · | -33.7% | · | |
| ROIC | · | -36.0% | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | · | 15.4 | · | |
| Quick Ratio | · | 15.1 | · |
Efficienza 2
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | |
| Receivables Turnover | · | 0.5 | · |
Tassi di Crescita 1
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | · | -99.2% | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $251.0K | · | |
| Net Income TTM | $-84M | $-65M | · | |
| Market Cap | · | $245M | · | |
| P/E | -1.3 | -1.7 | · | |
| P/S | · | 975.5 | · | |
| P/B | · | 1.3 | · | |
| P / Tangible Book | 0.9 | 1.3 | · | |
| P / Cash Flow | · | -4.4 | · | |
| P / FCF | · | -4.4 | · | |
| Earnings Yield | -80.0% | -57.6% | · |
Conto Economico 12
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $0 | $0 | $0 | $251.0K | $2M | |
| R&D Expense | $19M | $17M | $18M | $18M | $17M | $13M | $14M | $12M | $11M | $11M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $24M | $22M | $23M | $23M | $22M | $18M | $18M | $16M | $15M | $14M | |
| Operating Income | $-24M | $-22M | $-23M | $-23M | $-22M | $-18M | $-18M | $-16M | $-14M | $-12M | |
| Other Non-op | $2.0K | $-2.0K | $-3.0K | $-5.0K | $-4.0K | $-7.0K | $-6.0K | $23.0K | $147.0K | $168.0K | |
| Net Income | $-24M | $-21M | $-22M | $-21M | $-20M | $-16M | $-17M | $-18M | $-14M | $-12M | |
| EPS (Basic) | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| EPS (Diluted) | $-0.95 | $-0.85 | $-0.88 | $-0.87 | $-0.83 | $34.35 | $-0.92 | $-22.00 | $-17.24 | $-14.89 | |
| Shares (Basic) | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| Shares (Diluted) | 24,678,420 | -48,758,466 | 24,481,722 | 24,378,823 | 24,341,978 | -9,258,946 | 18,896,829 | 811,210 | 809,758 | 2,206 | |
| EBITDA | $-24M | · | $-23M | $-23M | $-22M | · | $-18M | $-16M | · | · |
Stato Patrimoniale 22
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $27M | $26M | $28M | $30M | $40M | $56M | $34M | · | $54M | |
| Short-term Investments | $66M | $81M | $97M | $114M | $136M | $145M | $91M | $12M | · | $23M | |
| Receivables | · | · | · | · | · | · | $569.0K | $569.0K | · | $1M | |
| Prepaid Expense | $2M | $5M | $6M | $7M | $4M | $3M | $3M | $2M | · | $1M | |
| Current Assets | $89M | $113M | $130M | $149M | $170M | $189M | $151M | $50M | · | $80M | |
| PP&E (Net) | $6M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | · | $8M | |
| PP&E (Gross) | $15M | $15M | $15M | $14M | $14M | $12M | $12M | $12M | · | $12M | |
| Accum. Depreciation | $9M | $8M | $8M | $7M | $7M | $6M | $5M | $5M | · | $4M | |
| Other Non-current Assets | $458.0K | $458.0K | $418.0K | $38.0K | $13.0K | $267.0K | $298.0K | $330.0K | · | $392.0K | |
| Total Assets | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Accounts Payable | $2M | $355.0K | $848.0K | $1M | $2M | $1M | $1M | $823.0K | · | $614.0K | |
| Accrued Liabilities | $6M | $10M | $7M | $6M | $6M | $7M | $8M | $6M | · | $8M | |
| Current Liabilities | $11M | $13M | $11M | $11M | $12M | $12M | $13M | $11M | · | $12M | |
| Capital Leases | $7M | $8M | $9M | $10M | $10M | $11M | $11M | $12M | · | $13M | |
| Other Non-current Liabilities | · | · | · | · | · | $73.0K | $73.0K | $74.0K | · | $73.0K | |
| Total Liabilities | $18M | $21M | $20M | $20M | $22M | $23M | $25M | $51M | · | $51M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | · | · | |
| Retained Earnings | $-354M | $-331M | $-310M | $-288M | $-267M | $-247M | $-231M | $-213M | · | $-181M | |
| AOCI | $-18.0K | $103.0K | $87.0K | $2.0K | · | $-129.0K | $338.0K | $121.0K | · | $308.0K | |
| Stockholders' Equity | $88M | $110M | $129M | $149M | $169M | $187M | $201M | $-191M | · | $-162M | |
| Liabilities + Equity | $106M | $131M | $149M | $169M | $191M | $210M | $226M | $76M | · | $105M | |
| Shares Outstanding | 24,716,672 | 24,291,607 | 24,544,904 | 24,393,524 | 24,363,119 | 24,291,607 | 24,287,144 | 814,202 | · | 809,758 |
Flusso di cassa 10
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $666.0K | $666.0K | $662.0K | $641.0K | $628.0K | $614.0K | $627.0K | $603.0K | $587.0K | $594.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-cash | $307.0K | · | · | · | $-2M | · | · | · | · | · | |
| Operating Cash Flow | $-21M | $-15M | $-19M | $-23M | $-20M | $-15M | $-12M | $-14M | $-15M | $-11M | |
| CapEx | $242.0K | $421.0K | $600.0K | $1M | $511.0K | $64.0K | $96.0K | $464.0K | $18.0K | $636.0K | |
| Investing Cash Flow | $15M | $16M | $16M | $21M | $10M | $-966.0K | $-131M | $1M | $10M | $-3M | |
| Stock Issued | · | · | · | · | · | $0 | · | · | · | · | |
| Financing Cash Flow | $-112.0K | $-121.0K | $-37.0K | $-72.0K | $239.0K | $-30.0K | $164M | · | · | $962.0K | |
| Net Change in Cash | $-6M | $1M | $-3M | $-2M | $-10M | $-16M | $22M | $-14M | $-5M | $-12M | |
| Free Cash Flow | $-21M | · | · | · | $-20M | · | · | · | · | · |
Redditività 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -15.8% | · | -11.5% | -17.3% | -21.2% | · | -15.5% | -47.0% | · | · | |
| ROE | -18.3% | · | -13.0% | 101.1% | -24.1% | · | -17.4% | 18.7% | · | · |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | · | 11.6 | 13.8 | 13.9 | · | 11.3 | 4.6 | · | · | |
| Quick Ratio | 8.0 | · | 11.1 | 13.2 | 13.6 | · | 11.1 | 4.4 | · | · |
Valutazione (TTM) 8
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-87M | · | $-81M | $-77M | $-70M | · | $-38M | $-32M | · | · | |
| Market Cap | $159M | · | $70M | $37M | $73M | · | $375M | · | · | · | |
| P/E | -1.8 | · | -0.8 | -0.1 | -0.1 | · | -0.4 | · | · | · | |
| P/B | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Tangible Book | 1.8 | · | 0.5 | 0.2 | 0.4 | · | 1.9 | · | · | · | |
| P / Cash Flow | -7.6 | · | · | · | -3.7 | · | · | · | · | · | |
| P / FCF | -7.5 | · | · | · | -3.6 | · | · | · | · | · | |
| Earnings Yield | -54.8% | · | -122.0% | -1630.5% | -1366.3% | · | -249.4% | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Ricavi | $0 | $251.0K | $33M |
| Margine Operativo % | — | -26805.6% | — |
| Utile netto | $-84M | $-65M | $-29M |
| EPS Diluito | $-3.43 | $-5.81 | $-35.78 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Rapporto corrente | — | 15.4 | — |
| Quick Ratio | — | 15.1 | — |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Flusso di cassa libero | — | $-56M | — |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.